Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hitzenberger

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
The metabolism of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in chimpanzee and manA G Zacchei, T I Wishousky, B H Arison, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Pharmacokinetic pilot study with imidazole 2-hydroxybenzoate using new analytical methodsH P Kuemmerle, G Hitzenberger, G Nieder, et al.
Wiener Klinische Wochenschrift|December 24, 1982
[Controlled randomized double-blind study for the comparison of the treatment of patients with essential hypertension with homeopathic and with pharmacologically effective drugs]G Hitzenberger, A Korn, M Dorcsi, et al.
Arzneimittel-Forschung|January 1, 1981
[Bioavailability studies of two spironolactone-preparations (author's transl)]H Vergin, U Nuss, F Schwarzländer, et al.
European Journal of Clinical Investigation|October 1, 1977
Effect of exercise and of prolonged oral administration of propranolol on haemodynamic variables, plasma renin concentration, plasma aldosterone and c-AMPJ Bonelli, W Waldhäusl, D Magometschnigg, et al.
Wiener Medizinische Wochenschrift (1946)|February 29, 1980
[Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)]P Schmidt, A Korn, G Hitzenberger, et al.
Pharmacotherapy|November 1, 1993
Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulationJ M Kovarik, E A Mueller, A Johnston, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1987
Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazoleU Ganzinger, F Schatz, H Haberl, et al.
Atherosclerosis|January 1, 1982
Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductaseJ A Tobert, G Hitzenberger, W R Kukovetz, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in manB Saletu, G Hitzenberger, J Grünberger, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
The metabolism of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in chimpanzee and manA G Zacchei, T I Wishousky, B H Arison, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Pharmacokinetic pilot study with imidazole 2-hydroxybenzoate using new analytical methodsH P Kuemmerle, G Hitzenberger, G Nieder, et al.
Wiener Klinische Wochenschrift|December 24, 1982
[Controlled randomized double-blind study for the comparison of the treatment of patients with essential hypertension with homeopathic and with pharmacologically effective drugs]G Hitzenberger, A Korn, M Dorcsi, et al.
Arzneimittel-Forschung|January 1, 1981
[Bioavailability studies of two spironolactone-preparations (author's transl)]H Vergin, U Nuss, F Schwarzländer, et al.
European Journal of Clinical Investigation|October 1, 1977
Effect of exercise and of prolonged oral administration of propranolol on haemodynamic variables, plasma renin concentration, plasma aldosterone and c-AMPJ Bonelli, W Waldhäusl, D Magometschnigg, et al.
Wiener Medizinische Wochenschrift (1946)|February 29, 1980
[Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)]P Schmidt, A Korn, G Hitzenberger, et al.
Pharmacotherapy|November 1, 1993
Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulationJ M Kovarik, E A Mueller, A Johnston, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1987
Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazoleU Ganzinger, F Schatz, H Haberl, et al.
Atherosclerosis|January 1, 1982
Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductaseJ A Tobert, G Hitzenberger, W R Kukovetz, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in manB Saletu, G Hitzenberger, J Grünberger, et al.
Pageof 8